Web of Science: 127 citations, Scopus: 136 citations, Google Scholar: citations,
Writers, readers and erasers of RNA modifications in cancer
Esteve-Puig, R. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Bueno-Costa, Alberto (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Universitat Autònoma de Barcelona

Date: 2020
Abstract: Although cancer was originally considered a disease driven only by genetic mutations, it has now been proven that it is also an epigenetic disease driven by DNA hypermethylation-associated silencing of tumor suppressor genes and aberrant histone modifications. Very recently, a third component has emerged: the so-called epitranscriptome understood as the chemical modifications of RNA that regulate and alter the activity of RNA molecules. In this regard, the study of genetic and epigenetic disruption of the RNA-modifying proteins is gaining momentum in advancing our understanding of cancer biology. Furthermore, the development of epitranscriptomic anticancer drugs could lead to new promising and unexpected therapeutic strategies for oncology in the coming years.
Grants: Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-1080
Agencia Estatal de Investigación RTI2018-094049-B-I00
Ministerio de Ciencia e Innovación SAF2014-55000
Note: Altres ajuts: MEFP/FPU17-02423
Rights: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades. Creative Commons
Language: Anglès
Document: Article de revisió ; Article ; Versió publicada
Subject: Epigenetics ; RNA modifications ; RNA-Editing ; RNA-Modifying enzymes
Published in: Cancer Letters, Vol. 474 (january 2020) , p. 127-137, ISSN 1872-7980

DOI: 10.1016/j.canlet.2020.01.021
PMID: 31991154


11 p, 1.8 MB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP) > Josep Carreras Leukaemia Research Institute
Articles > Published articles

 Record created 2021-02-02, last modified 2025-12-26



   Favorit i Compartir